Executive Summary

The global insomnia market is expected to grow at a CAGR of 5.8% during the forecast period (2021-2026), driven by factors such as increasing prevalence of sleep disorders, growing awareness of the importance of good sleep hygiene, and the availability of a wide range of treatment options. North America is expected to hold the largest share of the market, followed by Europe and Asia Pacific. Medications are the most widely used treatment option for insomnia, accounting for the largest share of the market. However, cognitive-behavioral therapy is gaining popularity as an effective non-pharmacological treatment option.

Important Note: The companies listed in the image above are for reference only. The final study will cover 18–20 key players in this market, and the list can be adjusted based on our client’s requirements.

Key Market Insights

• The global insomnia market is expected to grow at a CAGR of 5.8% during the forecast period (2021-2026).
• North America is expected to hold the largest share of the market, followed by Europe and Asia Pacific.
• Medications are the most widely used treatment option for insomnia, accounting for the largest share of the market.
• Cognitive-behavioral therapy is gaining popularity as an effective non-pharmacological treatment option.
• The growing trend towards personalized medicine is expected to drive the development of new insomnia treatments.

Market Drivers

• Increasing prevalence of sleep disorders: The growing prevalence of sleep disorders, including insomnia, is a major driver of the insomnia market. According to the American Sleep Association, around 50-70 million adults in the US have some form of sleep disorder.
• Growing awareness of the importance of good sleep hygiene: There is growing awareness of the importance of good sleep hygiene in maintaining overall health and well-being. This has led to an increased demand for products and services that can help improve sleep quality.
• Availability of a wide range of treatment options: There are several treatment options available for insomnia, including medication, cognitive-behavioral therapy, and lifestyle changes. This has led to a growing market for insomnia treatments.

Market Restraints

• Side effects of medication: Medications are the most widely used treatment option for insomnia, but they can have side effects such as drowsiness, dry mouth, and dizziness.
• High cost of treatment: Treatment for insomnia can be expensive, particularly for those without insurance coverage.
• Lack of reimbursement: Some treatments for insomnia are not covered by insurance, which can be a barrier to access for some patients.

Market Opportunities

• Development of new treatments: The growing trend towards personalized medicine is expected to drive the development of new insomnia treatments. This could include the development of new medications that are more targeted and have fewer side effects, as well as non-pharmacological treatments that are tailored to individual patients’ needs.
• Increasing use of digital health technologies: The use of digital health technologies, such as wearable devices and mobile apps, is on the rise. These technologies have the potential to improve sleep quality and provide personalized treatment options for insomnia.
• Growing demand for natural and herbal remedies: There is a growing demand for natural and herbal remedies for insomnia, as many people are concerned about the potential side effects of medications. This has led to the development of a wide range of natural and herbal sleep aids.

Market Dynamics

The insomnia market is characterized by intense competition and rapid innovation. There are a large number of players in the market, ranging from pharmaceutical companies to medical device manufacturers to digital health startups. These players are constantly developing new products and services to meet the needs of consumers, and the market is expected to continue to grow in the coming years.

Regional Analysis

North America is expected to hold the largest share of the insomnia market, followed by Europe and Asia Pacific. This can be attributed to factors such as the high prevalence of sleep disorders in these regions, the availability of advanced healthcare infrastructure, and a growing awareness of the importance of good sleep hygiene.

Competitive Landscape

Leading Companies in the Insomnia Market:

1. Eisai Co., Ltd.
2. Pfizer Inc.
3. Johnson & Johnson Services, Inc.
4. Merck & Co., Inc.
5. Sanofi S.A.
6. Takeda Pharmaceutical Company Limited
7. Vanda Pharmaceuticals Inc.
8. Pernix Therapeutics Holdings, Inc.
9. Meda Pharmaceuticals, Inc.
10. Neurim Pharmaceuticals Ltd

Please note: This is a preliminary list; the final study will feature 18–20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.

Segmentation

The insomnia market can be segmented based on product type, treatment type, and distribution channel. Product types include prescription sleep aids, over-the-counter sleep aids, and herbal and natural sleep aids. Treatment types include medication, cognitive-behavioral therapy, and lifestyle changes. Distribution channels include hospitals, clinics, retail pharmacies, and online pharmacies.

Category-wise Insights

• Prescription sleep aids: Prescription sleep aids are the largest category in the insomnia market, accounting for the majority of the market share. This is due to the high efficacy of prescription medications in treating insomnia.
• Over-the-counter sleep aids: Over-the-counter sleep aids are a popular option for people with mild to moderate insomnia. These products are widely available and can be purchased without a prescription.
• Herbal and natural sleep aids: Herbal and natural sleep aids are a growing segment of the market, as many people are looking for natural alternatives to prescription medications.

Key Benefits for Industry Participants and Stakeholders

• Opportunities for growth: The insomnia market is expected to continue to grow in the coming years, providing opportunities for companies to expand their product offerings and increase their market share.
• Diversification of product portfolios: Companies that offer a range of products and services for insomnia treatment are better positioned to succeed in the market.
• Collaborations and partnerships: Collaboration and partnerships with other players in the market can help companies gain a competitive edge and bring new products to market more quickly.

SWOT Analysis

Strengths:

• Growing market: The insomnia market is growing rapidly, providing opportunities for companies to expand their product offerings and increase their market share.
• Wide range of treatment options: There are a variety of treatment options available for insomnia, including medication, cognitive-behavioral therapy, and lifestyle changes.
• Increasing awareness of the importance of good sleep hygiene: There is growing awareness of the importance of good sleep hygiene in maintaining overall health and well-being.

Weaknesses:

• Side effects of medication: Medications used to treat insomnia can have side effects such as drowsiness, dry mouth, and dizziness.
• High cost of treatment: Treatment for insomnia can be expensive, particularly for those without insurance coverage.
• Lack of reimbursement: Some treatments for insomnia are not covered by insurance, which can be a barrier to access for some patients.

Opportunities:

• Development of new treatments: The growing trend towards personalized medicine is expected to drive the development of new insomnia treatments.
• Increasing use of digital health technologies: The use of digital health technologies, such as wearable devices and mobile apps, is on the rise. These technologies have the potential to improve sleep quality and provide personalized treatment options for insomnia.
• Growing demand for natural and herbal remedies: There is a growing demand for natural and herbal remedies for insomnia, as many people are concerned about the potential side effects of medications.

Threats:

• Intense competition: The insomnia market is highly competitive, with a large number of players vying for market share.
• Stringent regulatory requirements: Developing new insomnia treatments can be a lengthy and expensive process, due in part to the stringent regulatory requirements for pharmaceuticals and medical devices.
• Economic downturns: Economic downturns can lead to a decrease in consumer spending on healthcare products and services, which could negatively impact the insomnia market.

Market Key Trends

• Personalized medicine: The growing trend towards personalized medicine is expected to drive the development of new insomnia treatments that are tailored to individual patients’ needs.
• Non-pharmacological treatments: Non-pharmacological treatments, such as cognitive-behavioral therapy and lifestyle changes, are gaining popularity as effective alternatives to medication.
• Use of digital health technologies: The use of digital health technologies, such as wearable devices and mobile apps, is on the rise. These technologies have the potential to improve sleep quality and provide personalized treatment options for insomnia.

Covid-19 Impact

The COVID-19 pandemic has had a significant impact on the insomnia market. The pandemic has led to an increase in stress and anxiety, which can contribute to sleep disturbances and insomnia. In addition, the pandemic has disrupted sleep patterns for many people, as changes in work and school schedules have led to irregular sleep routines.

However, the pandemic has also led to an increased focus on the importance of good sleep hygiene, as people look for ways to maintain their health and well-being during this challenging time. This has created opportunities for companies that offer products and services that can help improve sleep quality.

Key Industry Developments

• In 2020, Eisai launched a new insomnia treatment called Dayvigo (lemborexant) in the US. Dayvigo is a dual orexin receptor antagonist that works by blocking the action of the wake-promoting neuropeptides orexin A and orexin B.
• In 2019, Merck & Co. announced that the FDA had approved its new insomnia drug, Belsomra (suvorexant). Belsomra is a dual orexin receptor antagonist that works by blocking the action of orexin, a neuropeptide that is involved in the regulation of sleep.
• In 2018, the American Academy of Sleep Medicine and the Sleep Research Society published new guidelines for the diagnosis and treatment of insomnia.

Analyst Suggestions

• Companies should focus on developing new insomnia treatments that are more effective and have fewer side effects than existing treatments.
• Companies should invest in research and development to explore the potential of non-pharmacological treatments for insomnia, such as cognitive-behavioral therapy and lifestyle changes.
• Companies should explore the use of digital health technologies, such as wearable devices and mobile apps, to provide personalized treatment options for insomnia.

Future Outlook

The insomnia market is expected to continue to grow in the coming years, driven by factors such as increasing prevalence of sleep disorders, growing awareness of the importance of good sleep hygiene, and the availability of a wide range of treatment options.

However, the insomnia market also faces several challenges, including intense competition, stringent regulatory requirements, and economic downturns. Companies will need to stay agile and innovative in order to stay ahead of the competition and meet the evolving needs of consumers.

Overall, the future outlook for the insomnia market is positive, with significant opportunities for growth and innovation. Companies that are able to develop effective, personalized, and cost-effective treatments for insomnia will be well-positioned to succeed in this rapidly growing market.

Conclusion

Insomnia is a common sleep disorder that affects millions of people worldwide. The growing prevalence of sleep disorders, increasing awareness of the importance of good sleep hygiene, and the availability of a wide range of treatment options are driving the growth of the insomnia market. The market is highly competitive, with a large number of players vying for market share, but also presents significant opportunities for growth and innovation.

The future of the insomnia market is expected to be characterized by the development of new, more effective treatments that are tailored to individual patients’ needs. The use of digital health technologies, such as wearable devices and mobile apps, is also expected to play a significant role in the future of the market. Companies that are able to stay agile and innovative will be well-positioned to succeed in this rapidly growing market.